Correlation Between Danske Bank and Orphazyme
Can any of the company-specific risk be diversified away by investing in both Danske Bank and Orphazyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Danske Bank and Orphazyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Danske Bank AS and Orphazyme AS, you can compare the effects of market volatilities on Danske Bank and Orphazyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Danske Bank with a short position of Orphazyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Danske Bank and Orphazyme.
Diversification Opportunities for Danske Bank and Orphazyme
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Danske and Orphazyme is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Danske Bank AS and Orphazyme AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orphazyme AS and Danske Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Danske Bank AS are associated (or correlated) with Orphazyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orphazyme AS has no effect on the direction of Danske Bank i.e., Danske Bank and Orphazyme go up and down completely randomly.
Pair Corralation between Danske Bank and Orphazyme
Assuming the 90 days trading horizon Danske Bank AS is expected to generate 0.35 times more return on investment than Orphazyme. However, Danske Bank AS is 2.86 times less risky than Orphazyme. It trades about 0.03 of its potential returns per unit of risk. Orphazyme AS is currently generating about 0.0 per unit of risk. If you would invest 19,210 in Danske Bank AS on September 3, 2024 and sell it today you would earn a total of 1,060 from holding Danske Bank AS or generate 5.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Danske Bank AS vs. Orphazyme AS
Performance |
| Timeline |
| Danske Bank AS |
| Orphazyme AS |
Danske Bank and Orphazyme Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Danske Bank and Orphazyme
The main advantage of trading using opposite Danske Bank and Orphazyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Danske Bank position performs unexpectedly, Orphazyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orphazyme will offset losses from the drop in Orphazyme's long position.| Danske Bank vs. Bavarian Nordic | Danske Bank vs. DSV Panalpina AS | Danske Bank vs. Vestas Wind Systems | Danske Bank vs. Ambu AS |
| Orphazyme vs. Zealand Pharma AS | Orphazyme vs. Ambu AS | Orphazyme vs. BioPorto | Orphazyme vs. Bavarian Nordic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |